TM6SF2 and Hepatic fibrosis: Notably, genetic polymorphism of TM6SF2 in the dominant model was independently linked to the risk of developing NAFLD, and PNPLA3 genetic variants additively increased vulnerability to NAFLD‐related hepatic fibrosis.